Related Experiment Videos
The diagnostic and predictive value of AI-combined multilayer spiral CT for MACE after emergency PCI in STEMI
1Department of Emergency, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang, China.
Insights
Artificial intelligence (AI) combined with coronary computed tomography angiography (CCTA) significantly improves risk prediction for major adverse cardiovascular events (MACE) in ST-segment elevation myocardial infarction (STEMI) patients after percutaneous coronary intervention (PCI). This AI-CCTA model offers superior accuracy compared to traditional scores.
Area of Science:
- Cardiology
- Medical Imaging
- Artificial Intelligence
Background:
- ST-segment elevation myocardial infarction (STEMI) patients face high risks of major adverse cardiovascular events (MACE) post-percutaneous coronary intervention (PCI).
- Traditional clinical scores have limitations in accurately stratifying MACE risk in these patients.
- Coronary computed tomography angiography (CCTA) offers detailed plaque visualization, but its integration with AI may enhance predictive capabilities.
Purpose of the Study:
- To evaluate the efficacy of an artificial intelligence (AI)-assisted coronary computed tomography angiography (CCTA) model in predicting 1-year MACE in STEMI patients post-PCI.
- To compare the predictive performance of the AI-CCTA model against traditional risk stratification tools, such as the GRACE score.
Main Methods:
- A prospective cohort study included 92 STEMI patients undergoing emergency PCI.
- Patients received 256-slice CCTA with AI analysis within 7 days post-PCI to quantify plaque characteristics.
- AI algorithms assessed total plaque volume, low-attenuation plaque, positive remodeling, and coronary artery calcium.
- Multivariate logistic regression and ROC curve analysis were used to determine predictive value for 1-year MACE.
Main Results:
- The AI-CCTA model, incorporating plaque volume >400 mm³, low-attenuation plaque, and left ventricular end-diastolic volume change, showed superior prediction of 1-year MACE.
- The AI-CCTA model achieved an area under the curve (AUC) of 0.876, significantly outperforming the GRACE score (AUC 0.742).
- Optimal cutoffs for the AI-CCTA model demonstrated high sensitivity (87.00%) and negative predictive value (93.60%).
Conclusions:
- AI-enhanced CCTA provides significant incremental value for predicting 1-year MACE in STEMI patients post-PCI, surpassing traditional risk scores.
- This integrated approach facilitates personalized risk assessment and may guide intensified follow-up strategies for high-risk individuals.
- AI-CCTA holds promise for improving patient management and outcomes in STEMI care.
Abstract:
ST-segment elevation myocardial infarction (STEMI) patients remain at substantial risk for major adverse cardiovascular events (MACE) following emergency percutaneous coronary intervention (PCI). The integration of artificial intelligence (AI) with coronary computed tomography angiography (CCTA) may enhance risk stratification beyond traditional clinical scores. This prospective cohort study enrolled 92 consecutive STEMI patients who underwent emergency PCI between June 2022 and June 2025. All patients underwent 256-slice CCTA with AI-assisted analysis within 7 days post-PCI. AI algorithms quantified plaque characteristics including total plaque volume, low-attenuation plaque burden, positive remodeling, and coronary artery calcium score. The primary endpoint was MACE (composite of cardiac death, recurrent myocardial infarction, target vessel revascularization, and heart failure hospitalization) at 1-year follow-up. Multivariate logistic regression and receiver operating characteristic (ROC) curve analysis were performed to assess predictive value. AI-enhanced multilayer spiral CT provides excellent discriminatory power for predicting 1-year MACE in STEMI patients post-PCI, offering significant incremental value beyond traditional risk stratification tools. This integrated approach enables personalized risk assessment and may guide intensified follow-up strategies in high-risk patients. During 12-month follow-up, MACE occurred in 23 patients (25.00%). The AI-CCTA model incorporating total plaque volume >400 mm3 (odds ratio [OR] 2.87, 95% confidence interval [CI]: 1.34-6.15, P = .007), low-attenuation plaque presence (OR 3.42, 95% CI: 1.28-9.14, P = .014), and left ventricular end-diastolic volume change (OR 2.64, 95% CI: 1.19-5.86, P = .017) demonstrated superior predictive performance. The combined AI-CCTA model achieved an area under the curve (AUC) of 0.876 (95% CI: 0.791-0.937), significantly outperforming the GRACE score alone (AUC 0.742, 95% CI: 0.639-0.829, P = .012). The optimal cutoff yielded a sensitivity of 87.00%, specificity of 79.70%, positive predictive value of 62.50%, and negative predictive value of 93.60%.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Imaging Studies for Cardiovascular System V: CT
Acute Coronary Syndrome I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care